These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23774598)

  • 1. Systemic CD14 inhibition attenuates organ inflammation in porcine Escherichia coli sepsis.
    Thorgersen EB; Pischke SE; Barratt-Due A; Fure H; Lindstad JK; Pharo A; Hellerud BC; Mollnes TE
    Infect Immun; 2013 Sep; 81(9):3173-81. PubMed ID: 23774598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs.
    Thorgersen EB; Hellerud BC; Nielsen EW; Barratt-Due A; Fure H; Lindstad JK; Pharo A; Fosse E; Tønnessen TI; Johansen HT; Castellheim A; Mollnes TE
    FASEB J; 2010 Mar; 24(3):712-22. PubMed ID: 19841036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ inflammation in porcine Escherichia coli sepsis is markedly attenuated by combined inhibition of C5 and CD14.
    Egge KH; Thorgersen EB; Pischke SE; Lindstad JK; Pharo A; Bongoni AK; Rieben R; Nunn MA; Barratt-Due A; Mollnes TE
    Immunobiology; 2015 Aug; 220(8):999-1005. PubMed ID: 25956456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood.
    Thorgersen EB; Pharo A; Haverson K; Axelsen AK; Gaustad P; Kotwal GJ; Sfyroera G; Mollnes TE
    Infect Immun; 2009 Feb; 77(2):725-32. PubMed ID: 19047409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined inhibition of complement C5 and CD14 markedly attenuates inflammation, thrombogenicity, and hemodynamic changes in porcine sepsis.
    Barratt-Due A; Thorgersen EB; Egge K; Pischke S; Sokolov A; Hellerud BC; Lindstad JK; Pharo A; Bongoni AK; Rieben R; Nunn M; Scott H; Mollnes TE
    J Immunol; 2013 Jul; 191(2):819-27. PubMed ID: 23761634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post challenge inhibition of C3 and CD14 attenuates Escherichia coli-induced inflammation in human whole blood.
    Egge KH; Thorgersen EB; Lindstad JK; Pharo A; Lambris JD; Barratt-Due A; Mollnes TE
    Innate Immun; 2014 Jan; 20(1):68-77. PubMed ID: 23669326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD14 inhibition improves survival and attenuates thrombo-inflammation and cardiopulmonary dysfunction in a baboon model of Escherichia coli sepsis.
    Keshari RS; Silasi R; Popescu NI; Regmi G; Chaaban H; Lambris JD; Lupu C; Mollnes TE; Lupu F
    J Thromb Haemost; 2021 Feb; 19(2):429-443. PubMed ID: 33174372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis.
    Frevert CW; Matute-Bello G; Skerrett SJ; Goodman RB; Kajikawa O; Sittipunt C; Martin TR
    J Immunol; 2000 May; 164(10):5439-45. PubMed ID: 10799910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-human CD14 monoclonal antibody improves survival following sepsis induced by endotoxin, but not following polymicrobial infection.
    Nakamura M; Takeuchi T; Shirakawa K; Furusako S
    Eur J Pharmacol; 2017 Jul; 806():18-24. PubMed ID: 28322834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of inhibiting MD-2 and CD14 on LPS- versus whole E. coli bacteria-induced cytokine responses in human blood.
    Christiansen D; Brekke OL; Stenvik J; Lambris JD; Espevik T; Mollnes TE
    Adv Exp Med Biol; 2012; 946():237-51. PubMed ID: 21948372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD14 in responses to clinical isolates of Escherichia coli: effects of K1 capsule expression.
    Metkar S; Awasthi S; Denamur E; Kim KS; Gangloff SC; Teichberg S; Haziot A; Silver J; Goyert SM
    Infect Immun; 2007 Nov; 75(11):5415-24. PubMed ID: 17709409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.
    Skjeflo EW; Christiansen D; Landsem A; Stenvik J; Woodruff TM; Espevik T; Nielsen EW; Mollnes TE
    Mol Immunol; 2019 Aug; 112():131-139. PubMed ID: 31102985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load.
    Egge KH; Barratt-Due A; Nymo S; Lindstad JK; Pharo A; Lau C; Espevik T; Thorgersen EB; Mollnes TE
    Clin Exp Immunol; 2015 Sep; 181(3):457-67. PubMed ID: 25907631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Toll-like Receptor 4-MD2 Complex.
    Gustavsen A; Nymo S; Landsem A; Christiansen D; Ryan L; Husebye H; Lau C; Pischke SE; Lambris JD; Espevik T; Mollnes TE
    J Infect Dis; 2016 Jul; 214(1):140-50. PubMed ID: 26977050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokines increase in sepsis after anti-adhesion molecule therapy.
    Welty-Wolf KE; Carraway MS; Ghio A; Kantrow SP; Huang YC; Piantadosi CA
    Shock; 2000 May; 13(5):404-9. PubMed ID: 10807017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of TNF-alpha or IL-1 beta does not affect E. coli-induced inflammation in human whole blood.
    Barratt-Due A; Thorgersen EB; Lindstad JK; Pharo A; Brekke OL; Christiansen D; Lambris JD; Mollnes TE
    Mol Immunol; 2010 May; 47(9):1774-82. PubMed ID: 20334922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition of complement C5 and CD14 attenuates inflammation in a cord blood model.
    Bjerkhaug AU; Granslo HN; Cavanagh JP; Høiland I; Ludviksen JK; Lau C; Espevik T; Mollnes TE; Klingenberg C
    Pediatr Res; 2023 Aug; 94(2):512-519. PubMed ID: 36725909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood.
    Brekke OL; Christiansen D; Fure H; Pharo A; Fung M; Riesenfeld J; Mollnes TE
    Mol Immunol; 2008 Aug; 45(14):3804-13. PubMed ID: 18606453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD14 release induced by P2X7 receptor restricts inflammation and increases survival during sepsis.
    Alarcón-Vila C; Baroja-Mazo A; de Torre-Minguela C; Martínez CM; Martínez-García JJ; Martínez-Banaclocha H; García-Palenciano C; Pelegrin P
    Elife; 2020 Nov; 9():. PubMed ID: 33135636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8,9-Dehydrohispanolone-15,16-lactol diterpene prevents LPS-triggered inflammatory responses by inhibiting endothelial activation.
    Jiménez-García L; Través PG; López-Fontal R; Herranz S; Higueras MA; de Las Heras B; Hortelano S; Luque A
    Biochem J; 2016 Jul; 473(14):2061-71. PubMed ID: 27154204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.